AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12439769 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (Caf, 250 mg)
Number of subjects: 8
Study 12439769 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 8
Study 10416555 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase exercise (N = 5)
Number of subjects: 9
Study 10416555 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase exercise (N = 4)
Number of subjects: 9
Study 10416555 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 6, 3 low volume exercise, 3 sedentary)
Number of subjects: 9
Study 10416555 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of menstrual cycle disruption
Number of subjects: 9
Study 8645964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (0.34 mg (kg body weight)‐1)
Number of subjects: 63
Study 8645964 — intervention group
Group type: COMPARATOR
Intervention: Intravenous midazolam (0.31 mg (kg body weight)‐1)
Number of subjects: 63
Study 8645964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam
Number of subjects: 63
Study 8645964 — intervention group
Group type: COMPARATOR
Intervention: Intravenous midazolam
Number of subjects: 63
Study 2188189 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in mean myopia from -1.43 to -3.06 D
Number of subjects: 238
Study 2188189 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in myopia
Number of subjects: 238
Study 2188189 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher spherical equivalent at end of study
Number of subjects: 238
Study 2188189 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher ASFE at end of study
Number of subjects: 238
Study 2188189 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing of spectacles
Number of subjects: 238
Study 7324823 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal diazepam (0.75 mg kg‐1)
Number of subjects: 0
Study 7324823 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diazepam premedications and a small dose of lytic cocktail (pethidine, promethazine, chlorpromazine) given i.m. during anaesthesia
Number of subjects: 0
Study 7324823 — intervention group
Group type: COMPARATOR
Intervention: Lytic cocktail (control)
Number of subjects: 0
Study 6387616 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymorphonuclear leukocyte transfusions every 12 hours for a total of five transfusions (15 mL/kg per transfusion)
Number of subjects: 23
Study 6387616 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 23
Study 29502081 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Referral Scheme (ERS) linked to community resources and social support for 12 weeks
Number of subjects: 422
Study 29502081 — intervention group
Group type: COMPARATOR
Intervention: Usual care from primary care practice
Number of subjects: 422
Study 27416494 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with OSA
Number of subjects: 796
Study 27416494 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with OSA
Number of subjects: 796
Study 24885816 — intervention group
Group type: EXPERIMENTAL
Intervention: Perilla frutescens extract
Number of subjects: 50
Study 24885816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 24885816 — intervention group
Group type: EXPERIMENTAL
Intervention: Perilla frutescens extract (women subgroup)
Number of subjects: 50
Study 23171244 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% SDF treatment
Number of subjects: 704
Study 23171244 — intervention group
Group type: EXPERIMENTAL
Intervention: ART sealant treatment
Number of subjects: 704
Study 23171244 — intervention group
Group type: COMPARATOR
Intervention: SDF treatment
Number of subjects: 704
Study 23171244 — intervention group
Group type: COMPARATOR
Intervention: Non-treated children
Number of subjects: 704
Study 23171244 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant-treated children
Number of subjects: 704
Study 20237046 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (500 μg via spacer device)
Number of subjects: 120
Study 20237046 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 120
Study 18697630 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance (NGT) at baseline
Number of subjects: 476
Study 18697630 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-diabetic at baseline
Number of subjects: 476
Study 18697630 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 476
Study 18697630 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal obesity
Number of subjects: 476
Study 18697630 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 476
Study 18697630 — intervention group
Group type: EXPERIMENTAL
Intervention: Indian Diabetes Risk Score (IDRS)
Number of subjects: 476
Study 15080014 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (starting dose 3 micrograms/kg per min)
Number of subjects: 40
Study 15080014 — intervention group
Group type: COMPARATOR
Intervention: Nitroprusside (starting dose 1 microgram/kg per min)
Number of subjects: 40
Study 11480466 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Back School
Number of subjects: 81
Study 11480466 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 81
Study 9444665 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-trinositol
Number of subjects: 0
Study 9444665 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sodium chloride)
Number of subjects: 0
Study 7936677 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocautery division of the thyroid isthmus during tracheostomy
Number of subjects: 0
Study 7936677 — intervention group
Group type: COMPARATOR
Intervention: Older techniques for division of the thyroid isthmus
Number of subjects: 0
Study 3281704 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM solution applied daily to mildly eczematous or clinically uninvolved skin for 5 days.
Number of subjects: 0
Study 3281704 — intervention group
Group type: EXPERIMENTAL
Intervention: HDM solution applied to normal, unabraded skin of prick test positive subjects without a history of dermatitis.
Number of subjects: 0
Study 3281704 — intervention group
Group type: COMPARATOR
Intervention: Vehicle or antigen solution applied to subjects negative on prick testing.
Number of subjects: 0
Study 29926910 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompting home-school cultural value conflict
Number of subjects: 161
Study 29926910 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompting family obligation (without mention of conflict)
Number of subjects: 161
Study 27687449 — intervention group
Group type: EXPERIMENTAL
Intervention: BARRIER EasyWarm blanket
Number of subjects: 246
Study 27687449 — intervention group
Group type: COMPARATOR
Intervention: Passive thermal insulation (control group)
Number of subjects: 246
Study 24489072 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sustained or diverted (NSD) episodes within 24 hours before inappropriate shock
Number of subjects: 185
Study 24489072 — intervention group
Group type: EXPERIMENTAL
Intervention: NSD episode within 14 minutes before shock
Number of subjects: 185
Study 24489072 — intervention group
Group type: EXPERIMENTAL
Intervention: NSD episodes in ALTITUDE-REDUCES Study
Number of subjects: 185
Study 23034957 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (20% from energy)
Number of subjects: 591
Study 23034957 — intervention group
Group type: COMPARATOR
Intervention: High-fat diet (40% from energy)
Number of subjects: 591
Study 20550022 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) treatment for 6 to 9 months
Number of subjects: 32
Study 20550022 — intervention group
Group type: COMPARATOR
Intervention: Hyperoxia
Number of subjects: 32
Study 20550022 — intervention group
Group type: COMPARATOR
Intervention: Hypercapnia (8% CO2)
Number of subjects: 32
Study 17394129 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour per week liaison input per home for 20 weeks to deliver a personalised intervention package
Number of subjects: 238
Study 17394129 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 238
Study 17394129 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour per week liaison input per home for 20 weeks
Number of subjects: 238
Study 15788475 — intervention group
Group type: EXPERIMENTAL
Intervention: Medihoney (honey)
Number of subjects: 101
Study 15788475 — intervention group
Group type: COMPARATOR
Intervention: Mupirocin (control)
Number of subjects: 101
Study 12071273 — intervention group
Group type: EXPERIMENTAL
Intervention: WALC intervention
Number of subjects: 17
Study 12071273 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 17
Study 9615962 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial tear treatment
Number of subjects: 60
Study 9615962 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (control group)
Number of subjects: 60
Study 7805977 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipple stimulation (15 min)
Number of subjects: 14
Study 7805977 — intervention group
Group type: EXPERIMENTAL
Intervention: Syntometrine injection
Number of subjects: 14
Study 7805977 — intervention group
Group type: COMPARATOR
Intervention: Control (no action)
Number of subjects: 14
Study 2505960 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (30 mg oral dose)
Number of subjects: 16
Study 2505960 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (2 mg intravenous dose)
Number of subjects: 16
Study 2505960 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 16
Study 1094320 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludrocortisone, 0.1 mg twice daily
Number of subjects: 6
Study 1094320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30742815 — intervention group
Group type: EXPERIMENTAL
Intervention: Low variable suction (−5 cm H2O)
Number of subjects: 106
Study 30742815 — intervention group
Group type: COMPARATOR
Intervention: High variable suction (−20 cm H2O)
Number of subjects: 106
Study 30742815 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 106
Study 28270204 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Classroom
Number of subjects: 181
Study 28270204 — intervention group
Group type: COMPARATOR
Intervention: Lecture‐Based Learning (LBL)
Number of subjects: 181
Study 27399127 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic aerobic cycling exercise
Number of subjects: 40
Study 27399127 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 24126064 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide 14 mg
Number of subjects: 324
Study 24126064 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide 7 mg
Number of subjects: 324
Study 24126064 — intervention group
Group type: COMPARATOR
Intervention: IFNβ‐1a
Number of subjects: 324
Study 24126064 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide
Number of subjects: 324
Study 22495146 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin matrix (PRFM) applied at the tendon-bone interface
Number of subjects: 79
Study 22495146 — intervention group
Group type: COMPARATOR
Intervention: Standard repair with no PRFM (Control)
Number of subjects: 79
Study 22495146 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin matrix (PRFM)
Number of subjects: 79
Study 19329389 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentil-based high protein diet (LenP)
Number of subjects: 31
Study 19329389 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-based high protein diet (AP)
Number of subjects: 31
Study 19329389 — intervention group
Group type: COMPARATOR
Intervention: Low protein diet (LP)
Number of subjects: 31
Study 17488411 — intervention group
Group type: EXPERIMENTAL
Intervention: GIK infusion (n = 14)
Number of subjects: 31
Study 17488411 — intervention group
Group type: COMPARATOR
Intervention: No-GIK (n = 17)
Number of subjects: 31
Study 17488411 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (GIK and No-GIK)
Number of subjects: 31
Study 17488411 — intervention group
Group type: EXPERIMENTAL
Intervention: GIK infusion
Number of subjects: 31
Study 15204277 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-verbal auditory alarms
Number of subjects: 0
Study 12228778 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I antiarrhythmic agents (secondary prevention after myocardial infarction)
Number of subjects: 0
Study 12228778 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 12228778 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0
Study 12228778 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators
Number of subjects: 0
Study 12228778 — intervention group
Group type: COMPARATOR
Intervention: Alternative therapy (most often amiodarone)
Number of subjects: 0
Study 10100392 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin addicts
Number of subjects: 116
Study 10100392 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 116
Study 8578181 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole daily for 6 months
Number of subjects: 220
Study 8578181 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg omeprazole daily for 6 months
Number of subjects: 220
Study 8578181 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 220
Study 8578181 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole daily for 4-8 weeks
Number of subjects: 220
Study 2189929 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-drug antiemetic regimen (metoclopramide, dexamethasone, diazepam, diphenhydramine, thiethylperazine)
Number of subjects: 13
Study 2189929 — intervention group
Group type: COMPARATOR
Intervention: High-dose metoclopramide
Number of subjects: 13
Study 707580 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 20
Study 707580 — intervention group
Group type: EXPERIMENTAL
Intervention: Promethazine
Number of subjects: 20
Study 707580 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone and Promethazine together
Number of subjects: 20
Study 707580 — intervention group
Group type: COMPARATOR
Intervention: Neither agent (control group)
Number of subjects: 20
Study 30732514 — intervention group
Group type: EXPERIMENTAL
Intervention: Loudness
Number of subjects: 0
Study 30732514 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitch
Number of subjects: 0
Study 30732514 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous effects of loudness and pitch
Number of subjects: 0
Study 31238061 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise videogames (EVGs) for 12 weeks
Number of subjects: 84
Study 31238061 — intervention group
Group type: COMPARATOR
Intervention: Standard exercise (e.g., treadmill, cycling)
Number of subjects: 84
Study 31238061 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 31238061 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise videogames (EVGs)
Number of subjects: 84
Study 28784038 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 50 mg TDS for 3 days
Number of subjects: 70
Study 28784038 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen 500 mg/6 h for 3 days
Number of subjects: 70
Study 28784038 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 70
Study 25932840 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-guided slow-paced respiration (n=61)
Number of subjects: 123
Study 25932840 — intervention group
Group type: COMPARATOR
Intervention: Control device (music-listening group, n=62)
Number of subjects: 123
Study 23889722 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination treatment with olmesartan medoxomil (OM) 40 mg, amlodipine besylate (AML) 10 mg, and hydrochlorothiazide (HCTZ) 25 mg
Number of subjects: 1555
Study 23889722 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination treatment
Number of subjects: 1555
Study 23889722 — intervention group
Group type: COMPARATOR
Intervention: Dual-combination treatments
Number of subjects: 1555
Study 21545395 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training plus resistance training (AT+RT)
Number of subjects: 30
Study 21545395 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 30
Study 19183161 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab pegol
Number of subjects: 1040
Study 17680721 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebral fracture cases
Number of subjects: 80
Study 17680721 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 80
Study 15054353 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary intervention (less than 20% energy from fat, five or more fruit/vegetable and six or more grain servings daily)
Number of subjects: 48836
Study 15054353 — intervention group
Group type: COMPARATOR
Intervention: Usual diet control
Number of subjects: 48836
Study 11459901 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 g/kg/day IVIg for 3 days
Number of subjects: 39
Study 11459901 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 g/kg/day IVIg for 6 days
Number of subjects: 39
Study 11459901 — intervention group
Group type: COMPARATOR
Intervention: Control group (3 days)
Number of subjects: 39
Study 11459901 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 days)
Number of subjects: 39
Study 9732070 — intervention group
Group type: EXPERIMENTAL
Intervention: Double therapy (ZDV + ddC or ddI)
Number of subjects: 169
Study 9732070 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (ZDV)
Number of subjects: 169
Study 9732070 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with baseline CD4+ lymphocyte count >350/microl
Number of subjects: 169
Study 9732070 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with BVL <10,000 HIV-1 RNA copies/ml
Number of subjects: 169
Study 9732070 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 169
Study 1597108 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal endoprostheses (M)
Number of subjects: 58
Study 1597108 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic endoprostheses (S)
Number of subjects: 58
Study 4051260 — intervention group
Group type: EXPERIMENTAL
Intervention: Papain (1 mg/mL)
Number of subjects: 500
Study 4051260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 4051260 — intervention group
Group type: EXPERIMENTAL
Intervention: Papain sensitivity
Number of subjects: 500
Study 4051260 — intervention group
Group type: EXPERIMENTAL
Intervention: Chymopapain
Number of subjects: 500
Study 31286927 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Conversation Map (DCM) education sessions (4 sessions, 40 minutes each over 4 weeks)
Number of subjects: 120
Study 31286927 — intervention group
Group type: COMPARATOR
Intervention: Routine Care (RC)
Number of subjects: 120
Study 29381568 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (10 mL) via ultrasound-guided LFC nerve block technique
Number of subjects: 20
Study 29381568 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 27054751 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC
Number of subjects: 1306
Study 27054751 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-DOC
Number of subjects: 1306
Study 25927297 — intervention group
Group type: EXPERIMENTAL
Intervention: NET (n = 10)
Number of subjects: 30
Study 25927297 — intervention group
Group type: EXPERIMENTAL
Intervention: NET-R (n = 10)
Number of subjects: 30
Study 25927297 — intervention group
Group type: COMPARATOR
Intervention: WL (n = 10)
Number of subjects: 30
Study 25927297 — intervention group
Group type: EXPERIMENTAL
Intervention: NET and NET-R
Number of subjects: 30
Study 25927297 — intervention group
Group type: EXPERIMENTAL
Intervention: NET-R
Number of subjects: 30
Study 22621316 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing statin + ezetimibe (simvastatin, atorvastatin or pravastatin + ezetimibe at doses of 20/10, 10/10 or 20/10 mg)
Number of subjects: 83
Study 22621316 — intervention group
Group type: COMPARATOR
Intervention: Doubling the dose of ongoing statin (simvastatin 40 mg, atorvastatin 20 mg or pravastatin 40 mg)
Number of subjects: 83
Study 19683989 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion initiated 5 days before surgery
Number of subjects: 70
Study 19683989 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem infusion before removing the RA
Number of subjects: 70
Study 17603846 — intervention group
Group type: EXPERIMENTAL
Intervention: 10(6.7) focus‐forming units of the attenuated RIX4414 human rotavirus vaccine
Number of subjects: 319
Study 17603846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study 15389239 — intervention group
Group type: EXPERIMENTAL
Intervention: IVUS guidance during PCI
Number of subjects: 9069
Study 15389239 — intervention group
Group type: COMPARATOR
Intervention: Angiography guidance during PCI
Number of subjects: 9069
Study 11524061 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine-based regimen with additional antihypertensive drugs as needed
Number of subjects: 508
Study 11524061 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 508
Study 9647534 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FSH (Gonal-F) 150 IU
Number of subjects: 7
Study 9647534 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FSH (Gonal-F) 37.5 IU
Number of subjects: 7
Study 9647534 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FSH (Gonal-F) 75 IU
Number of subjects: 7
Study 9647534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 8596135 — intervention group
Group type: EXPERIMENTAL
Intervention: rh‐GM‐CSF (5 micrograms/kg s.c. daily for 7 days)
Number of subjects: 11
Study 2198807 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent virus vaccine (measles AIK‐C strain, mumps Hoshino strain, rubella Takahashi strain)
Number of subjects: 1369
Study 2198807 — intervention group
Group type: COMPARATOR
Intervention: Monovalent measles vaccine (AIK‐C strain)
Number of subjects: 1369